US 11,944,724 B2
In situ forming hemostatic foam implants
Upma Sharma, Somerville, MA (US); Irina Gitlin, Brookline, MA (US); Gregory T. Zugates, Chelmsford, MA (US); Adam Rago, Falmouth, MA (US); Parisa Zamiri, Brookline, MA (US); Rany Busold, Medford, MA (US); Robert J. Caulkins, Watertown, MA (US); Toby Freyman, Lexington, MA (US); Quynh Pham, Methuen, MA (US); Changcheng You, Northbridge, MA (US); and Jeffrey Carbeck, Belmont, MA (US)
Assigned to ARSENAL MEDICAL, INC., Watertown, MA (US)
Filed by ARSENAL MEDICAL, INC., Watertown, MA (US)
Filed on Dec. 13, 2021, as Appl. No. 17/548,844.
Application 17/548,844 is a division of application No. 16/376,087, filed on Apr. 5, 2019, granted, now 11,246,964.
Application 14/928,857 is a division of application No. 13/209,020, filed on Aug. 12, 2011, granted, now 9,173,817, issued on Nov. 3, 2015.
Application 16/376,087 is a continuation of application No. 14/928,857, filed on Oct. 30, 2015, granted, now 10,307,515, issued on Jun. 4, 2019.
Application 13/209,020 is a continuation in part of application No. 12/862,362, filed on Aug. 24, 2010, abandoned.
Claims priority of provisional application 61/368,095, filed on Jul. 27, 2010.
Claims priority of provisional application 61/236,314, filed on Aug. 24, 2009.
Prior Publication US 2022/0105248 A1, Apr. 7, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 31/06 (2006.01); A61B 17/12 (2006.01); A61J 1/20 (2006.01); A61L 27/18 (2006.01); A61L 27/56 (2006.01); A61L 27/58 (2006.01); A61L 31/14 (2006.01); A61M 37/00 (2006.01); C08L 63/00 (2006.01)
CPC A61L 31/06 (2013.01) [A61B 17/12031 (2013.01); A61B 17/12163 (2013.01); A61B 17/12186 (2013.01); A61J 1/2093 (2013.01); A61L 27/18 (2013.01); A61L 27/56 (2013.01); A61L 27/58 (2013.01); A61L 31/141 (2013.01); A61L 31/146 (2013.01); A61L 31/148 (2013.01); A61M 37/00 (2013.01); C08L 63/00 (2013.01); A61B 2017/12004 (2013.01); A61L 2400/04 (2013.01); A61L 2400/06 (2013.01); A61L 2400/18 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A system for forming a medical implant to limit movement of a bodily fluid, comprising:
a first composition and second composition, the second composition being physically separated from the first composition; a mechanism configured to mix the first composition with the second composition to form a mixture having a first volume; and a device configured to be insertable into a body of a patient, the device configured to permit the flow of the mixture of the first and second compositions into a body cavity of the patient, wherein the mixture of the first composition with the second composition forms a polymeric material that undergoes a volume expansion of at least 12× compared to the first volume.